A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Abramson Cancer Center at Penn Medicine
AvenCell Therapeutics, Inc.
Seoul National University Hospital
University of Maryland, Baltimore
Vitebsk Regional Clinical Cancer Centre